News & Insights
Sort By
Insights 1 result
Insights
|June 18, 2018
Gunderson Dettmer represented WindMIL Therapeutics, Inc. in latest financing round
Gunderson Dettmer served as lead counsel to WindMIL Therapeutics in its $32.5 million Series B financing round led by Qiming Venture Partners USA with participation from Medivate Partners, Camden Partners Nexus, Domain Associates and FOXKISER.
Client News 27 Results
Client News
|March 21, 2025
Fast Company Recognized 20 Gunderson Dettmer Clients in 2025 World’s Most Innovative Companies List
20 Gunderson Dettmer clients are recognized in Fast Company's 2025 World’s Most Innovative Companies list, which ranks innovative companies across 58 industries and sectors
Client News
|March 20, 2025
Gunderson Dettmer Represented Boston Celtics In Pending Sale
Boston Basketball Partners, led by the Grousbeck family and owner of the Boston Celtics, announces its definitive agreement to sell the team to an investor group led by William Chisholm
Client News
|December 18, 2024
VC Firm Benchstrength Announces $62M Debut Fund
NYC-based venture capital firm, Benchstrength, announces its $62 million debut fund
Firm News 16 Results
Firm News
|October 18, 2024
19 Gunderson Dettmer attorneys are recognized in the 2025 edition of Lawdragon's 500 Leading Dealmakers in America list, highlighting their expertise in various practice areas
Firm News
|August 15, 2024
Best Lawyers Recognizes 29 Gunderson Dettmer Attorneys in the 2025 Best Lawyers in America Guide
29 Gunderson Dettmer attorneys were recognized in Best Lawyers' 2025 Best Lawyers in America Guide
Firm News
|June 14, 2024
Gunderson Dettmer Practice Areas and Partners Recognized by Chambers USA in 2024 Guide
The 2024 Chambers and Partners Guide recognized Gunderson Dettmer as a leading law firm in ten (10) departments. This year, Gunderson Dettmer’s highly-ranked practice areas include: Private Equity: Fund Formation, Private Equity: Venture Capital Investment, Technology, Employee Benefits & Executive Compensation, and more.